Forum Alvasoft.net
accueil
s'inscrire
aide
recherche
Répondre au sujet
Pseudo
Mot de passe
Vous avez oublié votre mot de passe ?
Message
[quote=jiraporn66][url=https://www.img.in.th/images/dd1bc427e557dff9a47f14df2b2262d9.jpg] Pfizer announces[url=https://168slotxo.com/]SLOTXO[/url]successful COVID drug treatment Reduce hospitalizations and deaths Up to 89% of high-risk patients prepare to apply for emergency use in the United States. On November 5, 2021, Bloomberg reported that Pfizer Inc. announced that its COVID-19 drug reduces hospitalizations and deaths in high-risk patients by 89%. The company expects the results to help improve treatment for the coronavirus. After the announcement of this news Pfizer Inc shares jumped 11% in the pre-market session. The American drugmaker said in a statement that The company will no longer accept new patients for trials. Due to the overwhelming efficacy of the drug And the company plans to send the study results to US regulators. for emergency use approval as soon as possible Pfizer's results So there are now two drugmakers that offer early-stage treatments for COVID patients. Last month, Merck & Co and Ridgeback Biotherapeutics LP shipped their experimental drugs to US agencies. The study showed it could halve the risk of serious illness or death in mild-to-moderate coronavirus patients. Tablets that can be taken at home from the onset of symptoms. It is an important tool to control the global covid crisis. In the case of widespread distribution A Pfizer spokesperson also said: After applying for approval for use in the United States The company will soon apply for approval to use it to other regulators. Pfizer tested the drug on 1,219 unvaccinated adults five days after treatment. It was found that the drug can greatly reduce the rate of hospitalization. When taking the drug after the onset of symptoms within 3 or 5 days A drug called Paxlovid binds to an enzyme called protease to stop the virus from multiplying. Some HIV drugs work the same way. Overall, only 0.8% of people started treatment within 3 days of becoming ill. However, no one died from the trial, while 7% of those who took the placebo. There are both hospitalizations and deaths. For those who received the drug within 5 days of showing symptoms The results were similar in those who received the drug within 3 days of showing symptoms.[/quote]
autres
Mise en forme :
Noir
Rouge foncé
Rouge
Orange
Marron
Jaune
Vert
Olive
Cyan
Bleu
Bleu foncé
Indigo
Violet
Powered by
Phedio
v3.6 © dew
Contacter l'administrateur
- 3.8 ms